Howard Marks - Oaktree Capital Management
Holding/activity history for Sorrento Therapeutics, Inc. (SRNE)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2023 Q1 | 134,000 | <0.01 | $0.36 | $48,239 | SEC | ||
| 2022 Q4 | 134,000 | <0.01 | $0.89 | $118,724 | SEC | ||
| 2022 Q3 | 134,000 | <0.01 | $1.57 | $210,000 | SEC | ||
| 2022 Q2 | 134,000 | 3.80 | Reduce 10.67% | <0.01 | $2,007.46 | $269,000,000 | SEC |
| 2022 Q1 | 150,000 | <0.01 | $2.33 | $349,000 | SEC | ||
| 2021 Q4 | 150,000 | 0.01 | Add 11.94% | <0.01 | $4.65 | $697,000 | SEC |
| 2021 Q3 | 134,000 | 0.02 | $7.63 | $1,023,000 | SEC | ||
| 2021 Q2 | 134,000 | 0.02 | Reduce 58.13% | 0.02 | $9.68 | $1,297,000 | SEC |
| 2021 Q1 | 320,000 | 0.04 | Buy | 0.04 | $8.27 | $2,646,000 | SEC |
| 2020 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2020 Q2 | 100,500 | 0.02 | Buy | 0.02 | $6.28 | $631,000 | SEC |